Prednisone vs Placebo and Live Birth in Patients With Recurrent Implantation Failure Undergoing In Vitro Fertilization

医学 活产 强的松 胚胎移植 安慰剂 体外受精 随机对照试验 怀孕 妊娠期 相对风险 产科 妇科 内科学 置信区间 病理 替代医学 生物 遗传学
作者
Yun Sun,Linlin Cui,Yao Lu,Jichun Tan,Xi Dong,Tianxiang Ni,Junhao Yan,Yichun Guan,Guimin Hao,Jiayin Liu,Bo Zhang,Daimin Wei,Yan Hong,Yaqiong He,Jia Qi,Bing Xu,Juanjuan Lu,Qian Zhang,Shanshan Zhao,Xiaowei Ji
出处
期刊:JAMA [American Medical Association]
卷期号:329 (17): 1460-1460 被引量:61
标识
DOI:10.1001/jama.2023.5302
摘要

Importance: Implantation failure remains a critical barrier to in vitro fertilization. Prednisone, as an immune-regulatory agent, is widely used to improve the probability of implantation and pregnancy, although the evidence for efficacy is inadequate. Objective: To determine the efficacy of 10 mg of prednisone compared with placebo on live birth among women with recurrent implantation failure. Design, Setting, and Participants: A double-blind, placebo-controlled, randomized clinical trial conducted at 8 fertility centers in China. Eligible women who had a history of 2 or more unsuccessful embryo transfer cycles, were younger than 38 years when oocytes were retrieved, and were planning to undergo frozen-thawed embryo transfer with the availability of good-quality embryos were enrolled from November 2018 to August 2020 (final follow-up August 2021). Interventions: Participants were randomized (1:1) to receive oral pills containing either 10 mg of prednisone (n = 357) or matching placebo (n = 358) once daily, from the day at which they started endometrial preparation for frozen-thawed embryo transfer through early pregnancy. Main Outcomes and Measures: The primary outcome was live birth, defined as the delivery of any number of neonates born at 28 or more weeks' gestation with signs of life. Results: Among 715 women randomized (mean age, 32 years), 714 (99.9%) had data available on live birth outcomes and were included in the primary analysis. Live birth occurred among 37.8% of women (135 of 357) in the prednisone group vs 38.8% of women (139 of 358) in the placebo group (absolute difference, -1.0% [95% CI, -8.1% to 6.1%]; relative ratio [RR], 0.97 [95% CI, 0.81 to 1.17]; P = .78). The rates of biochemical pregnancy loss were 17.3% in the prednisone group and 9.9% in the placebo group (absolute difference, 7.5% [95% CI, 0.6% to 14.3%]; RR, 1.75 [95% CI, 1.03 to 2.99]; P = .04). Of those in the prednisone group, preterm delivery occurred among 11.8% and of those in the placebo group, 5.5% of pregnancies (absolute difference, 6.3% [95% CI, 0.2% to 12.4%]; RR, 2.14 [95% CI, 1.00 to 4.58]; P = .04). There were no statistically significant between-group differences in the rates of biochemical pregnancy, clinical pregnancy, implantation, neonatal complications, congenital anomalies, other adverse events, or mean birthweights. Conclusions and Relevance: Among patients with recurrent implantation failure, treatment with prednisone did not improve live birth rate compared with placebo. Data suggested that the use of prednisone may increase the risk of preterm delivery and biochemical pregnancy loss. Our results challenge the value of prednisone use in clinical practice for the treatment of recurrent implantation failure. Trial Registration: Chinese Clinical Trial Registry Identifier: ChiCTR1800018783.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
dmdgling完成签到,获得积分10
1秒前
1秒前
1秒前
无花果的应助被科研一路绿灯采纳,获得10
2秒前
查找发布了新的文献求助20
3秒前
奶茶电竞精神完成签到,获得积分10
4秒前
老实人完成签到,获得积分10
6秒前
浮生发布了新的文献求助10
6秒前
Unstoppable完成签到,获得积分10
6秒前
嗯哼完成签到 ,获得积分10
6秒前
高大河马发布了新的文献求助10
7秒前
标致的秋荷完成签到,获得积分10
7秒前
linglingling完成签到 ,获得积分10
7秒前
科研通AI6.3的应助被邵蹦蹦采纳,获得10
8秒前
8秒前
Cong完成签到,获得积分10
8秒前
xbnie完成签到,获得积分10
9秒前
阳阳秋完成签到,获得积分10
11秒前
12秒前
GUAN发布了新的文献求助10
12秒前
Lucas的应助被你真是那个啊采纳,获得10
12秒前
13秒前
努力加油干的小猫咪完成签到 ,获得积分10
13秒前
福yyy发布了新的文献求助10
16秒前
jianghuren发布了新的文献求助10
17秒前
Zz发布了新的文献求助10
18秒前
zxzx发布了新的文献求助10
20秒前
horse完成签到,获得积分10
20秒前
TOT完成签到,获得积分10
21秒前
天天快乐的应助被绪绪采纳,获得10
21秒前
22秒前
24秒前
24秒前
lila完成签到,获得积分10
27秒前
27秒前
27秒前
27秒前
浮生发布了新的文献求助20
28秒前
trx发布了新的文献求助10
28秒前
csy完成签到,获得积分10
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186750
求助须知:如何正确求助?哪些是违规求助? 9575027
关于积分的说明 21839240
捐赠科研通 7784331
什么是DOI,文献DOI怎么找? 3434808
关于科研通互助平台的介绍 2559206
邀请新用户注册赠送积分活动 2481611